Drug-coated balloon angioplasty for dialysis access fistula stenosis
Maintaining vascular access patency represents a tremendous challenge in hemodialysis patients. Although “native” arteriovenous fistula (AVF) is currently recommended as primary vascular access, neointimal hyperplasia stenoses frequently develop, with a risk for AVF thrombosis and vascular access loss. For years, first-line treatment of AVFs stenoses has been percutaneous transluminal angioplasty, generally with high-pressure or cutting uncoated balloons. However, restenosis and reintervention rates remain incredibly high and occur, according to recent studies, in up to 60% and 70% of patients at 6 and 12 months, respectively.
Source: Seminars in Vascular Surgery - Category: Surgery Authors: Aur éline Boitet, Ziad A. Massy, Olivier Goeau-Brissonniere, Isabelle Javerliat, Marc Coggia, Raphaël Coscas Source Type: research
More News: Angioplasty | Baloon Angioplasty | Dialysis | Hemodialysis | Peripheral Angioplasty | Study | Surgery | Thrombosis